Jenson Qi

764 total citations
21 papers, 613 citations indexed

About

Jenson Qi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Jenson Qi has authored 21 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in Jenson Qi's work include Pancreatic function and diabetes (10 papers), Diabetes Treatment and Management (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Jenson Qi is often cited by papers focused on Pancreatic function and diabetes (10 papers), Diabetes Treatment and Management (7 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Jenson Qi collaborates with scholars based in United States, Belgium and Australia. Jenson Qi's co-authors include Lawrence de Garavilla, Charles E. Smith, Bruce E. Maryanoff, William A. Kinney, Patricia Andrade‐Gordon, Lisa Minor, Yuanping Wang, Diane K. Luci, Shyamali Ghosh and Andrew L. Darrow and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Diabetes.

In The Last Decade

Jenson Qi

20 papers receiving 605 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenson Qi United States 13 269 249 184 162 115 21 613
Qiu Guo United States 16 224 0.8× 662 2.7× 135 0.7× 37 0.2× 65 0.6× 26 932
David B. Rawlins United States 11 178 0.7× 231 0.9× 269 1.5× 57 0.4× 199 1.7× 17 614
Denise Blum‐Kaelin Switzerland 9 222 0.8× 173 0.7× 145 0.8× 29 0.2× 65 0.6× 11 445
Gisela Stahnke United States 13 214 0.8× 216 0.9× 207 1.1× 31 0.2× 43 0.4× 16 604
June O’Neil United States 17 121 0.4× 380 1.5× 83 0.5× 22 0.1× 62 0.5× 23 768
Monica Einstein United States 10 109 0.4× 432 1.7× 410 2.2× 55 0.3× 88 0.8× 14 826
Corey Miller United States 7 103 0.4× 180 0.7× 172 0.9× 75 0.5× 43 0.4× 7 378
Weston Lane United States 8 84 0.3× 491 2.0× 97 0.5× 62 0.4× 57 0.5× 12 596
W. R. Ingebretsen United States 15 177 0.7× 251 1.0× 149 0.8× 17 0.1× 130 1.1× 24 688
R Saperstein United States 9 74 0.3× 519 2.1× 103 0.6× 57 0.4× 63 0.5× 17 703

Countries citing papers authored by Jenson Qi

Since Specialization
Citations

This map shows the geographic impact of Jenson Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenson Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenson Qi more than expected).

Fields of papers citing papers by Jenson Qi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenson Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenson Qi. The network helps show where Jenson Qi may publish in the future.

Co-authorship network of co-authors of Jenson Qi

This figure shows the co-authorship network connecting the top 25 collaborators of Jenson Qi. A scholar is included among the top collaborators of Jenson Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenson Qi. Jenson Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jianying, Hui Huang, Jenson Qi, et al.. (2022). A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates. Frontiers in Endocrinology. 13. 1061688–1061688. 7 indexed citations
2.
Qi, Jenson, et al.. (2021). GRK Inhibition Potentiates Glucagon-Like Peptide-1 Action. Frontiers in Endocrinology. 12. 4 indexed citations
3.
Xu, Guozhang, Michael D. Gaul, Zhi‐Jie Liu, et al.. (2020). Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor. Bioorganic & Medicinal Chemistry Letters. 30(23). 127602–127602. 3 indexed citations
4.
Kuo, Gee‐Hong, Micheal D. Gaul, Yin Liang, et al.. (2018). Synthesis and biological evaluation of benzocyclobutane-C-glycosides as potent and orally active SGLT1/SGLT2 dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 28(7). 1182–1187. 29 indexed citations
5.
Huang, Hui, Sanath K. Meegalla, James C. Lanter, et al.. (2018). Discovery of a GPR40 Superagonist: The Impact of Aryl Propionic Acid α-Fluorination. ACS Medicinal Chemistry Letters. 10(1). 16–21. 18 indexed citations
6.
Rives, M., Shuyuan Zhao, Jenson Qi, et al.. (2018). GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets. Molecular Pharmacology. 93(6). 581–591. 22 indexed citations
7.
Greco, Michael N., Mark J. Macielag, Christopher A. Teleha, et al.. (2018). 6-Benzhydryl-4-amino-quinolin-2-ones as Potent Cannabinoid Type 1 (CB1) Receptor Inverse Agonists and Chemical Modifications for Peripheral Selectivity. Journal of Medicinal Chemistry. 61(22). 10276–10298. 12 indexed citations
8.
Liu, Jianying, Tonya Martin, Sanath K. Meegalla, et al.. (2018). FFAR1 Agonism Restores Insulin Secretion in Rodents, Human Islets, and Diabetic Monkeys. Diabetes. 67(Supplement_1). 1 indexed citations
9.
Qi, Jenson, John A. Masucci, Wensheng Lang, et al.. (2017). Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors. SLAS DISCOVERY. 22(4). 433–439.
10.
Qi, Jenson, Wensheng Lang, Margery A. Connelly, et al.. (2016). Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo. Analytical Biochemistry. 524. 68–75. 1 indexed citations
11.
Kuriyama, Chiaki, Jun Xu, Jenson Qi, et al.. (2014). Analysis of the Effect of Canagliflozin on Renal Glucose Reabsorption and Progression of Hyperglycemia in Zucker Diabetic Fatty Rats. Journal of Pharmacology and Experimental Therapeutics. 351(2). 423–431. 34 indexed citations
12.
Qi, Jenson, Wensheng Lang, John G. Geisler, et al.. (2012). The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2. Journal of Lipid Research. 53(6). 1106–1116. 89 indexed citations
13.
Qi, Jenson, Wensheng Lang, Edward C. Giardino, et al.. (2010). High-content assays for evaluating cellular and hepatic diacylglycerol acyltransferase activity. Journal of Lipid Research. 51(12). 3559–3567. 21 indexed citations
14.
Luci, Diane K., Edward C. Lawson, Shyamali Ghosh, et al.. (2009). Generation of novel, potent urotensin-II receptor antagonists by alkylation–cyclization of isoindolinone C3-carbanions. Tetrahedron Letters. 50(35). 4958–4961. 30 indexed citations
15.
Luci, Diane K., Shyamali Ghosh, Charles E. Smith, et al.. (2007). Phenylpiperidine-benzoxazinones as urotensin-II receptor antagonists: Synthesis, SAR, and in vivo assessment. Bioorganic & Medicinal Chemistry Letters. 17(23). 6489–6492. 14 indexed citations
16.
Zhang, Andrew Y., Yafei Chen, David X. Zhang, et al.. (2003). Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney. American Journal of Physiology-Renal Physiology. 285(4). F792–F798. 85 indexed citations
17.
Darrow, Andrew L., Kelly A. Conway, Anil H. Vaidya, et al.. (2003). Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening. SLAS DISCOVERY. 8(1). 65–71. 8 indexed citations
18.
Pitson, Stuart M., Paul A.B. Moretti, Julia R. Zebol, et al.. (2002). The Nucleotide-binding Site of Human Sphingosine Kinase 1. Journal of Biological Chemistry. 277(51). 49545–49553. 90 indexed citations
19.
Kinney, William A., Harold R. Almond, Jenson Qi, et al.. (2002). StructureâFunction Analysis of Urotensin II and Its Use in the Construction of a LigandâReceptor Working Model. Angewandte Chemie International Edition. 41(16). 2940–2940. 73 indexed citations
20.
Kinney, William A., Harold R. Almond, Jenson Qi, et al.. (2002). StructureâFunction Analysis of Urotensin II and Its Use in the Construction of a LigandâReceptor Working Model. Angewandte Chemie. 114(16). 3064–3064. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026